Company intelligence / Profile preview

SITES Medical

Columbia City, Indiana, United States

Ownership: Private
Employees: ~35
Development stage: Other

Overview

SITES Medical's OsteoSync Ti technology has achieved over 250,000 device implantations, with increasing market adoption due to best-in-class bone ingrowth and initial stability. Their solutions are integrated into OEM partners’ branded implants utilized in orthopedic, spine, and dental procedures.

Therapeutic areas: RheumatologyOther
Modalities: DeviceNanoparticlePolymer-based technologyBiologic coating
Industry: Implantable Medical Devices

Partnerships

Medtronic (acquired technology for next-generation PEEK interbody fusion devices)Microport (Evolution Tibial Cones using OsteoSync Ti)Spineology (Duo Ti Expandable Interbody Fusion Procedure)Various orthopedic OEMs (multiple partnerships; most OEM brands undisclosed)

Beyond the preview

Go deeper on SITES Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SITES Medical.

Explore the full profile